Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 2/2012

01.03.2012 | Original Paper

Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders

verfasst von: Victor Peralta, Virginia Basterra, Maria S. Campos, Elena García de Jalón, Lucía Moreno-Izco, Manuel J. Cuesta

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Spontaneous Parkinsonism (SP) in schizophrenia-related disorders is poorly characterized. The objective of this study was to examine the concordance and clinical validity of alternative definitions of SP in patients with nonaffective psychotic disorders. Two-hundred drug-naive patients with nonaffective psychotic disorders were examined for core parkinsonian signs, including bradykinesia, rigidity, and tremor, and diagnosed of SP according to the Simpson-Angus Scale (SAS) cutoff criterion, the UK Parkinson’s disease brain bank (UKPDBB) criteria, the National Institute of Neurological Disorders and Stroke (NINDS) criteria, and criteria requiring the presence of all three core features (full syndrome criteria). Parkinsonian signs and criteria were examined in relation to a number of relevant clinical variables. The most frequent sign was rigidity (33.5%) followed by bradykinesia (16%) and tremor (12%). The prevalence rate of SP according to the SAS cutoff criterion, the UKPDBB criteria, the NINDS criteria for possible and probable SP, and the full syndrome criteria were 20.5, 13, 25.5, 18.5, and 4%, respectively. Bradykinesia was specifically related to negative symptoms, rigidity to neurological soft signs, and tremor to dyskinetic movements. The set of criteria showing more associations with clinical variables were the NINDS criteria for probable SP. Patients fulfilling these criteria had higher ratings for poor premorbid adjustment, negative symptoms, dyskinesia, neurological soft signs, and poor global treatment response than those without that diagnosis. The NINDS criteria for probable SP, i.e., presence of any two of the three core parkinsonian signs, seem to be the most suitable for clinical and research purposes.
Literatur
1.
Zurück zum Zitat Kraepelin E (1913) Dementia Praecox and Paraphrenia (Trans: Barklay RM). Livingstone, Edinburgh Kraepelin E (1913) Dementia Praecox and Paraphrenia (Trans: Barklay RM). Livingstone, Edinburgh
2.
Zurück zum Zitat Wolff AS, O’Driscoll GA (1999) Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk. J Psychiatry Neurosci 24:304–314PubMed Wolff AS, O’Driscoll GA (1999) Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk. J Psychiatry Neurosci 24:304–314PubMed
3.
Zurück zum Zitat Pappa S, Dazzan P (2009) Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review. Psychol Med 39:1065–1076PubMedCrossRef Pappa S, Dazzan P (2009) Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review. Psychol Med 39:1065–1076PubMedCrossRef
4.
Zurück zum Zitat Whitty PF, Owoeye O, Waddington J (2009) Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull 35:415–424PubMedCrossRef Whitty PF, Owoeye O, Waddington J (2009) Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull 35:415–424PubMedCrossRef
5.
Zurück zum Zitat Peralta V, Campos MS, García de Jalón E, Cuesta MJ (2010) Motor behavior abnormalities in drug-naive patients with schizophrenia spectrum disorders. Mov Disord 25:1068–1076PubMedCrossRef Peralta V, Campos MS, García de Jalón E, Cuesta MJ (2010) Motor behavior abnormalities in drug-naive patients with schizophrenia spectrum disorders. Mov Disord 25:1068–1076PubMedCrossRef
6.
Zurück zum Zitat Günther W, Günther R, Eich FX, Eben E (1986) Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. II Cross validation study on schizophrenic patients: persistence of a “psychotic motor syndrome” as possible evidence of an independent biological marker syndrome for schizophrenia. Eur Arch Psychiatry Clin Neurosci 235:301–308 Günther W, Günther R, Eich FX, Eben E (1986) Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. II Cross validation study on schizophrenic patients: persistence of a “psychotic motor syndrome” as possible evidence of an independent biological marker syndrome for schizophrenia. Eur Arch Psychiatry Clin Neurosci 235:301–308
7.
Zurück zum Zitat Torrey F (2002) Studies of individuals with schizophrenia never treated with antipsychotic drugs: a review. Schizophr Res 58:101–115PubMedCrossRef Torrey F (2002) Studies of individuals with schizophrenia never treated with antipsychotic drugs: a review. Schizophr Res 58:101–115PubMedCrossRef
8.
Zurück zum Zitat Caligiuri MP, Lohr JB, Jeste DV (1993) Parkinsonism in neuroleptic-naive schizophrenic patients. Am J Psychiatry 150:1343–1348PubMed Caligiuri MP, Lohr JB, Jeste DV (1993) Parkinsonism in neuroleptic-naive schizophrenic patients. Am J Psychiatry 150:1343–1348PubMed
9.
Zurück zum Zitat Chatterjee A, Chakos M, Koreen A, Geisler S, Sheitman B, Woerner M, Kane JM, Alvir J, Lieberman JA (1995) Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry 152:1724–1729PubMed Chatterjee A, Chakos M, Koreen A, Geisler S, Sheitman B, Woerner M, Kane JM, Alvir J, Lieberman JA (1995) Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry 152:1724–1729PubMed
10.
Zurück zum Zitat Honer WG, Kopala LC, Rabinowitz J (2005) Extrapyramidal symptoms and signs in first-episode, antipsychotic-exposed and non-exposed patients with schizophrenia or related psychotic illness. J Psychopharmachol 19:277–285CrossRef Honer WG, Kopala LC, Rabinowitz J (2005) Extrapyramidal symptoms and signs in first-episode, antipsychotic-exposed and non-exposed patients with schizophrenia or related psychotic illness. J Psychopharmachol 19:277–285CrossRef
11.
Zurück zum Zitat McCreadie RG, Padmavati R, Thara R, Srinivasan TN (2002) Spontaneous dyskinesia and Parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-up. Br J Psychiatry 181:135–137PubMedCrossRef McCreadie RG, Padmavati R, Thara R, Srinivasan TN (2002) Spontaneous dyskinesia and Parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-up. Br J Psychiatry 181:135–137PubMedCrossRef
12.
Zurück zum Zitat Cortese L, Caligiuri MP, Malla AK, Manchanda R, Takhar J, Haricharan R (2005) Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic naïve schizophrenia patients. Schizophr Res 75:65–75PubMedCrossRef Cortese L, Caligiuri MP, Malla AK, Manchanda R, Takhar J, Haricharan R (2005) Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic naïve schizophrenia patients. Schizophr Res 75:65–75PubMedCrossRef
13.
Zurück zum Zitat Zielasek J, Gaebel W (2008) Modern modularity and the road towards a modular psychiatry. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):60–65PubMedCrossRef Zielasek J, Gaebel W (2008) Modern modularity and the road towards a modular psychiatry. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):60–65PubMedCrossRef
14.
Zurück zum Zitat Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Arbizu J, Giménez-Amaya JM (2002) The basal ganglia and disorders of movement. News Physiol Sci 17:51–55PubMed Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Arbizu J, Giménez-Amaya JM (2002) The basal ganglia and disorders of movement. News Physiol Sci 17:51–55PubMed
15.
Zurück zum Zitat Hoeppner J, Prudente-Morrissey L, Herpertz SC, Benecke R, Walter U (2009) Substantia nigra hyperechogenicity in depressive subjects relates to motor assimetry and impaired word fluency. Eur Arch Psychiatry Clin Neurosci 259:92–97PubMedCrossRef Hoeppner J, Prudente-Morrissey L, Herpertz SC, Benecke R, Walter U (2009) Substantia nigra hyperechogenicity in depressive subjects relates to motor assimetry and impaired word fluency. Eur Arch Psychiatry Clin Neurosci 259:92–97PubMedCrossRef
16.
Zurück zum Zitat Kuhn J, Gaebel W, Klosterkoetter J, Woopen C (2009) Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment. Eur Arch Psychiatry Clin Neurosci 259(Suppl 2):135–141CrossRef Kuhn J, Gaebel W, Klosterkoetter J, Woopen C (2009) Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment. Eur Arch Psychiatry Clin Neurosci 259(Suppl 2):135–141CrossRef
17.
Zurück zum Zitat Tuppurainen H, Kuikka JT, Laakso MP, Viinamäki H, Husso M, Tiihonen J (2006) Midbrain dopamine D2/3 receptor binding in schizophrenia. Eur Arch Psychiatry Clin Neurosci 256:382–387PubMedCrossRef Tuppurainen H, Kuikka JT, Laakso MP, Viinamäki H, Husso M, Tiihonen J (2006) Midbrain dopamine D2/3 receptor binding in schizophrenia. Eur Arch Psychiatry Clin Neurosci 256:382–387PubMedCrossRef
18.
Zurück zum Zitat Rogers D (1985) The motor disorders of severe psychiatric illness: a conflict of paradigms. Br J Psychiatry 147:221–232PubMedCrossRef Rogers D (1985) The motor disorders of severe psychiatric illness: a conflict of paradigms. Br J Psychiatry 147:221–232PubMedCrossRef
19.
Zurück zum Zitat Möller H-J, Müller H, Borison RL, Schooler NR, Chouinard G (1995) A path-analytical approach to differentiate between direct and indirect drug-effects on negative symptoms of schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 245:45–49PubMedCrossRef Möller H-J, Müller H, Borison RL, Schooler NR, Chouinard G (1995) A path-analytical approach to differentiate between direct and indirect drug-effects on negative symptoms of schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 245:45–49PubMedCrossRef
20.
Zurück zum Zitat Peralta V, Cuesta MJ (2010) The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: a naturalistic study with haloperidol, risperidone or olanzapine. Prim Care Companion. J Clin Psychiatry 12:1–11 Peralta V, Cuesta MJ (2010) The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: a naturalistic study with haloperidol, risperidone or olanzapine. Prim Care Companion. J Clin Psychiatry 12:1–11
21.
Zurück zum Zitat American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington
22.
Zurück zum Zitat Andreasen NC, Flaum M, Arndt S (1992) The comprehensive assessment of symptoms and diagnosis. An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49:615–623PubMedCrossRef Andreasen NC, Flaum M, Arndt S (1992) The comprehensive assessment of symptoms and diagnosis. An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49:615–623PubMedCrossRef
23.
Zurück zum Zitat Peralta V, Cuesta MJ (2011) Neuromotor abnormalities in neuroleptic-naïve psychotic patients: antecedents, clinical correlates and prediction of treatment response. Comp Psychiatry 52:139–145CrossRef Peralta V, Cuesta MJ (2011) Neuromotor abnormalities in neuroleptic-naïve psychotic patients: antecedents, clinical correlates and prediction of treatment response. Comp Psychiatry 52:139–145CrossRef
24.
Zurück zum Zitat Harris JG (1975) Abbreviated form of the Phillips rating scale of premorbid adjustment in schizophrenia. J Abnorm Psychol 84:129–137PubMedCrossRef Harris JG (1975) Abbreviated form of the Phillips rating scale of premorbid adjustment in schizophrenia. J Abnorm Psychol 84:129–137PubMedCrossRef
25.
Zurück zum Zitat Perkins DO, Leserman J, Jarskog LF, Graham K, Kazmer J, Lieberman JA (2000) Characterizing and dating the onset of symptoms in psychotic illness: the symptom onset in schizophrenia (SOS) inventory. Schizophr Res 44:1–10PubMedCrossRef Perkins DO, Leserman J, Jarskog LF, Graham K, Kazmer J, Lieberman JA (2000) Characterizing and dating the onset of symptoms in psychotic illness: the symptom onset in schizophrenia (SOS) inventory. Schizophr Res 44:1–10PubMedCrossRef
26.
Zurück zum Zitat Guy W (1976) ECDEU assessment manual for psychopharmacology. Government Printing Office, US Washington Guy W (1976) ECDEU assessment manual for psychopharmacology. Government Printing Office, US Washington
27.
Zurück zum Zitat Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side-effects. Acta Psychiatr Scand 212(suppl. 44):11–19CrossRef Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side-effects. Acta Psychiatr Scand 212(suppl. 44):11–19CrossRef
28.
29.
Zurück zum Zitat Lund CE, Mortimer AM, Rogers D, McKenna PJ (1991) Motor, volitional and behavioural disorders in schizophrenia 1: assessment using the modified Rogers scale. Br J Psychiatry 158:323–327PubMedCrossRef Lund CE, Mortimer AM, Rogers D, McKenna PJ (1991) Motor, volitional and behavioural disorders in schizophrenia 1: assessment using the modified Rogers scale. Br J Psychiatry 158:323–327PubMedCrossRef
30.
Zurück zum Zitat Buchanan RW, Heinrichs DW (1989) The neurological evaluation scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatr Res 27:335–350CrossRef Buchanan RW, Heinrichs DW (1989) The neurological evaluation scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatr Res 27:335–350CrossRef
31.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef
32.
Zurück zum Zitat Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39PubMedCrossRef Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39PubMedCrossRef
33.
Zurück zum Zitat Grove WM, Andreasen NC (1982) Simultaneous test of many hypotheses in exploratory research. J Nerv Mental Dis 170:3–7CrossRef Grove WM, Andreasen NC (1982) Simultaneous test of many hypotheses in exploratory research. J Nerv Mental Dis 170:3–7CrossRef
34.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism. Onset, progression and mortality. Neurology 17:427–442PubMed Hoehn MM, Yahr MD (1967) Parkinsonism. Onset, progression and mortality. Neurology 17:427–442PubMed
35.
Zurück zum Zitat Reichmann H (2010) Clinical criteria for the diagnosis of Parkinson’s disease. Neurodegener Dis 7:284–290PubMedCrossRef Reichmann H (2010) Clinical criteria for the diagnosis of Parkinson’s disease. Neurodegener Dis 7:284–290PubMedCrossRef
36.
Zurück zum Zitat Peralta V, Cuesta MJ (1999) Negative, parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr Res 40:245–253PubMedCrossRef Peralta V, Cuesta MJ (1999) Negative, parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr Res 40:245–253PubMedCrossRef
37.
Zurück zum Zitat Peralta V, Cuesta MJ, Martinez-Larrea A, Serrano JF (2000) Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment. Am J Psychiatry 157:1461–1466PubMedCrossRef Peralta V, Cuesta MJ, Martinez-Larrea A, Serrano JF (2000) Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment. Am J Psychiatry 157:1461–1466PubMedCrossRef
38.
Zurück zum Zitat Strous RD, Alvir JMG, Robinson D, Gal G, Sheirman B, Chakos, Lieberman JA (2004) Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects. Schizophr Bull 30:265–278PubMedCrossRef Strous RD, Alvir JMG, Robinson D, Gal G, Sheirman B, Chakos, Lieberman JA (2004) Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects. Schizophr Bull 30:265–278PubMedCrossRef
39.
Zurück zum Zitat Jimenez-Jimenez F, Ortí-Pareja M, Ayuso-Peralta L, Gasalla T, Cabrera-Valdivia F, Vaquero A et al (1996) Drug-induced Parkinsonism in a movement disorder clinic. Parkinsonism Relat Disord 2:145–149PubMedCrossRef Jimenez-Jimenez F, Ortí-Pareja M, Ayuso-Peralta L, Gasalla T, Cabrera-Valdivia F, Vaquero A et al (1996) Drug-induced Parkinsonism in a movement disorder clinic. Parkinsonism Relat Disord 2:145–149PubMedCrossRef
40.
Zurück zum Zitat Geschwandtner U, Pflüger M, Aston J, Borgwardt S, Drewe M, Stieglitz R-D, Riecher-Rössler A (2006) Fine motor function and neuropsychological deficits in individuals at risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 256:201–206 Geschwandtner U, Pflüger M, Aston J, Borgwardt S, Drewe M, Stieglitz R-D, Riecher-Rössler A (2006) Fine motor function and neuropsychological deficits in individuals at risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 256:201–206
Metadaten
Titel
Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders
verfasst von
Victor Peralta
Virginia Basterra
Maria S. Campos
Elena García de Jalón
Lucía Moreno-Izco
Manuel J. Cuesta
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 2/2012
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-011-0219-1

Weitere Artikel der Ausgabe 2/2012

European Archives of Psychiatry and Clinical Neuroscience 2/2012 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.